On track to complete enrollment of first two cohorts of RAD204 following positive recommendation from DSMC to escalate dose to…
The Phase 3 clinical trial of sovateltide, RESPECT-ETB, is expected to enroll over 500 patients with a primary endpoint of…
TORONTO, July 28, 2025 /PRNewswire/ -- Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging…
Peer-reviewed research published in Redox Biology supports the therapeutic potential of Cannabinol (CBN) in brain aging and metabolic health.Correction from…
Fueled by successful community and clinical screenings, Linus Health brings its AI-powered remote cognitive assessment platform to payers, pharma, wellness…
Bringing early detection of cognitive impairment to the forefront of health plan CX — empowering personalized, proactive brain health BOSTON…
Analysis of first-in-class CNS-101 study validates that at-home endpoints showed greater separation with Alzheimer's pathology (pTau217) than the benchmark endpoint…
Interim results from the CARE PMR study support the use of ultra-low-field MRI as a triage tool for monitoring patients…
Interim results from the CARE PMR study support the use of ultra-low-field MRI as a triage tool for monitoring patients…
Troculeucel, a cryopreserved autologous, non-genetically modified NK cell product, appears to cross the blood brain barrier (BBB) via CXCR3, to…